LGALS3 and carcinoma: Five additional proteins were studied: carcinoma stem cell markers: TRA-1-60 [42], CD326 (epithelial cell adhesion molecule, EpCAM) [43], galectin-3 (GAL-3) [44], the immune checkpoint inhibitor CD274 (programmed cell death ligand-1, PD-L1) [45] and carcinoma marker pan-keratin (cytokeratins) [46].